Inflammatory bowel syndrome

Research News


ELEVATE seed grants to help researchers at The Ottawa Hospital improve treatment for inflammatory and immune conditions
February 21, 2024 - The Ottawa Hospital’s Research Institute is awarding four ELEVATE seed grants to help researchers understand the role of inflammation and the immune system in various diseases and develop better treatments.
Researchers update guidance on colorectal cancer screening in patients with IBDs
November 4, 2021 - Dr. Sanjay Murthy was the lead author in a Clinical Practice Update (CPU) for the American Gastroenterological Association on how to prevent, detect and manage colorectal neoplastic lesions in patients with inflammatory bowel diseases (IBDs) based on
Are we using biologic therapy properly?
June 13, 2019 - The introduction of infliximab (Remicade), the first biologic therapy approved for the treatment of inflammatory bowel diseases (IBD), did not result in lower rates of hospitalizations or intestinal surgeries among patients living with IBD in Ontario
Show more news stories


Researchers


Name Scientific appointment Diseases, conditions and populations of interest Research and clinical approaches
El-Chaar, Darine
MD, FRCSC, Msc
Scientist
(Clinical Epidemiology)
Autoimmune disease, COVID-19, Diabetes, Infectious disease, Inflammatory bowel syndrome, Maternal and fetal health, Newborn and child health, Population health, Pregnancy, Women's health Clinical research, Clinical trials, Cohort studies, Epidemiology, Health research methods, Health services research, Public health, Qualitative methods, Quality Improvement, Systematic reviews
Murthy, Sanjay
MD, FRCPC
Scientist
(Clinical Epidemiology)
Colorectal cancer, Crohn's, Gastrointestinal disease, Inflammatory bowel syndrome Clinical decision rules, Clinical research, Cohort studies, Epidemiology, Health economics, Health services research
Presseau, Justin
PhD
Senior Scientist
(Clinical Epidemiology)
Chronic disease, Chronic pain, COVID-19, Diabetes, Health equity, Hepatitis C, Immigrant and refugee health, Inflammatory bowel syndrome, Retinal disease, Vision Artificial intelligence and data science, Health services research, Patient engagement, Psychometrics, Public health, Qualitative methods, Quality Improvement, Rapid reviews, Transfusions, Transplantation, Behaviour, Psychology, Health professional behaviour change, Knowledge translation and implementation research, Health promotion, Cluster randomized trials, Surveys
Schlossmacher, Michael
MD, DABPN, FRCPC
Program Director and
Senior Scientist
(Neuroscience)
Aging, Brain and neuromuscular disease, Chronic disease, Crohn's, Dementia, Inflammatory bowel syndrome, Dementia, Parkinson's Basic research, Biomarkers, Cohort studies, Disease models, Drug development, Genetics, Lipidomics, Molecular and cellular biology, Proteomics, Risk assessment, Transgenic/knockout models, Translational research


Related Resources

Search for clinical trials at The Ottawa Hospital related to this disease or condition.